Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial

Date
2011
Author
Buyukberber, S.
Kilickap, S.
Buyukunal, E.
Camci, C.
Sencan, O.
Yalcin, S.
Uslu, R.
Dane, F.
Yilmaz, U.
Zengin, N.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/153201
https://doi.org/10.1200/jco.2011.29.15_suppl.3579
Collections